Abstract:Objective To investigate the changes of interleukin-21 (IL 21) and interleukin-21 receptor (IL 21R) expression level in Crohn's disease (CD) patients before and after accepted infliximab (IFX) treatment.Methods From June 2009 to July 2011,twenty-two CD patients met the research criteria were recruited at Tenth People's Hospital of Tongji University.Patients were treated with infliximab at weeks 0,2,6,and 16 healthy individuals were set as healthy control group at same time.Peripheral blood of healthy control group was taken at regular physical examination and blood of CD patients was taken before treatment and 10 weeks after treatment,intestinal mucosa biopsy samples were taken under colon endoscopy examination.The changes of Crohn's disease activity index (CDAI),erythrocyte sedimentation rate (ESR),C-reactive protein (CRP) in CD patients were observed.The change of IL-21R in peripheral blood CD4+ T lymphocytes was detected by flow cytometry.The change of IL-21 expression at mRNA level in intestinal mucosa was determined by realtime quantitative polymerase chain reaction (PCR).The data were analyzed by t test.Results Before treatment,the level of IL21R in peripheral blood CD4+ T lymphocytes of CD patients (12.25％±3.25％) and the expression of IL-21 at mRNA level in inflamed intestinal mucosa (1.38±0.32) were both significantly higher than those of healthy controls (4.25 ％ ± 1.41％,0.44±0.18),the differences were statistically significant (F=15.88,6.75 ; both P＜0.05).At 10th week,the level of IL-21R in peripheral blood CD4+ T lymphocytes of CD patients (8.12％ ± 2.05％) and the expression of IL-21 at mRNA level in intestinal mucosa (0.77 ± 0.24) were both significantly lower than those before treatment,the differences were statistically significant ( t=4.880,8.019; both P＜0.01).Before treatment,ESR,CRP and CDAI of CD patients was (46.8±11.4) mm/1 h,(52.4±11.5) mg/L and 319±74,which was (23.5±9.0) mm/1 h,(11.6±4.6) mg/L and 113±42 after treatment,the differences were statistically significant (t=9.485,16.458,11.100; all P＜0.05).Conclusion The IL-21 expression of active CD patients decreases after IFX treatment,which indicates that IL-21 may involve in IFX induced clinical remission of active CD.

The Relationship Between CD4~+ CD25~+ Regulatory T Cells and the Pathogenesis of Crohn's Disease

Alterations of Th17/Treg Cells in Peripheral Blood and Serum Inflammatory Biomarkers in Patients with Crohn's Disease and Its Clinical Significance

Imbalances of CD4(+) T-cell subgroups in Crohn's disease and their relationship with disease activity and prognosis.

The Role of CD4+CD25+T Cells in Different Stages of Ulcerative Colitis

Effect of IL-12 on peripheral blood and lamina propria lymphocyte activation and proinflammatory cytokine secretion in patients with inflammatory bowel disease

Immune Regulation of Interleukin-23 on Peripheral Blood Natural Killer Cell in Patients with Inflammatory Bowel Disease

Elevated Levels of IL-27 Are Associated with Disease Activity in Patients with Crohn's Disease

IL-25 Downregulates Th1/Th17 Immune Response in an IL-10–Dependent Manner in Inflammatory Bowel Disease

Decreased Lamina Propria Effector Cell Responsiveness to Interleukin-10 in Ileal Crohn's Disease.

Alterations of T cell subsets and cytokines levels in patients with Crohn's disease following Infliximab therapy

Effects of Infliximab Induced Clinical Remission of Active Crohn's Disease on the Level of Interleukin-21 and Interleukin-21 Receptor

Expression of miRNA-21 in colonic mucosa and peripheral blood CD4+ T cells of 49 patients with active inflammatory bowel disease

Significance of interleukin-27 expression in the intestinal mucosa of patients with inflammatory bowel disease

Study on Activation of CD27-CD70 Co-Stimulatory Pathway in Patients with Inflammatory Bowel Disease

[Relationship of CD4+ CD25hi Regulatory T (treg) Cells to Disease Progression in HIV-infected Patients].

Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease

[Imbalance of CD4(+) T Cell Subgroups in Ulcerative Colitis].

Cytotoxic T Lymphocyte-associated Antigen 4 Expression on Surface of Peripheral Blood Mononuclear Cells in Patients with Inflammatory Bowel Disease

Hyperactivation and enhanced cytotoxicity of reduced CD8+ gamma delta T cells in the intestine of patients with Crohn's disease correlates with disease activity

High Levels of Serum Soluble Cytotoxic T Lymphocyte Associated Antigen 4 and Its Clinical Significance in Patients with Crohn's Disease

Study of CD4+Foxp3+ Regulatory T Cells in Peripheral Blood of Adult Minimal Change Disease